Advertisement

Topics

Pancreatic Cancer Action Network Company Profile

02:49 EST 25th November 2017 | BioPortfolio

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research -- and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.


News Articles [3511 Associated News Articles listed on BioPortfolio]

Yankees Pitcher David Robertson Aims to Strike Out Pancreatic Cancer

MANHATTAN BEACH, Calif., Oct. 3, 2017 /PRNewswire-USNewswire/ -- As the Major League Baseball (MLB) playoffs begin today, New York Yankees relief pitcher David Robertson will be aiming to strike ...

Pancreatic Cancer Action Network Invests in Precision Medicine and Early Detection to Change Outcomes for the World’s Toughest Cancer

The Pancreatic Cancer Action Network (PanCAN) is driving research progress by targeting precision medicine and early detection methods for the world’s toughest cancer. Th...

Chemotherapy for Pancreatic Cancer, Part 5: Chemotherapy for Metastatic Pancreatic Cancer

_kmq.push(["trackClickOnOutboundLink","link_59de5e0895dc8","Article link clicked",{"Title":"","Page":"Chemotherapy for Pancreatic Cancer, Part 5: Chemotherapy for Metastatic Pancreatic Cancer"}]);Dr. ...

Twin Cities Turns Purple to End Pancreatic Cancer on September 16

MINNEAPOLIS, Aug. 29, 2017 /PRNewswire-USNewswire/ -- The Twin Cities will turn purple as thousands participate in PurpleRideStride Minnesota, the road to end pancreatic cancer on Sept. 16. The commun...

What is resectable pancreatic cancer?

Both the National Comprehensive Cancer Network (NCCN) and the American Joint Commission on Cancer (AJCC) staging systems suggest that the definition of “resectable” pancreatic cancer is straightfo...

Advanced Pancreatic Cancer: Changing Landscape Signals Hope

Pancreatic cancer, though relatively uncommon, is the fourth most common of cancer-related deaths. In the United States, 44,030 new cases of pancreatic cancer were diagnosed with 37,660 deaths in 2011...

Chemotherapy for Pancreatic Cancer, Part 6: Moving Forward in Advanced Pancreatic Cancer

_kmq.push(["trackClickOnOutboundLink","link_59de5e088f09e","Article link clicked",{"Title":"","Page":"Chemotherapy for Pancreatic Cancer, Part 6: Moving Forward in Advanced Pancreatic Cancer"}]);Dr. C...

Chemotherapy for Pancreatic Cancer, Part 3: Pre-Operative Treatment for Pancreatic Cancer

_kmq.push(["trackClickOnOutboundLink","link_59de5e08a4271","Article link clicked",{"Title":"","Page":"Chemotherapy for Pancreatic Cancer, Part 3: Pre-Operative Treatment for Pancreatic Cancer"}]);Dr. ...

PubMed Articles [8996 Associated PubMed Articles listed on BioPortfolio]

KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.

Pancreatic cancer is highly malignant and characterised by rapid and uncontrolled growth. While some of the important regulatory networks involved in pancreatic cancer have been determined, the cancer...

MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor.

Although microRNA-296 (miR-296) has been studied in various types of human cancer, its expression, biological role and mechanism of action in pancreatic cancer remains to be elucidated. The aim of the...

The clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancer.

We aimed to identify STK31 as a cancer-testis (CT) gene and to explore its potential clinical value, regulatory mechanisms, and gene network in pancreatic cancer (PC). Gene expression data were genera...

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.

Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systemati...

Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.

The role of conventional radiotherapy in the management of pancreatic cancer has yet to be elucidated. Over the past decade, stereotactic body radiotherapy (SBRT) has emerged as a novel therapeutic op...

Clinical Trials [8978 Associated Clinical Trials listed on BioPortfolio]

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The i...

Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue

Pancreatic cancer is a very aggressive cancer. Over the past 40 years there has not been much progress made in reducing deaths from this cancer. Recently, new models of pancreatic cancers ...

Local Invasion of Pancreatic Cancer

Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microsco...

Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with or without chemotherapy and chemoradiation.

Optimizing the Efficacy of Multimodality Therapies for Pancreatic Cancer

This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effec...

Companies [2274 Associated Companies listed on BioPortfolio]

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

Pancreatic Cancer Action

About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

More Information about "Pancreatic Cancer Action Network" on BioPortfolio

We have published hundreds of Pancreatic Cancer Action Network news stories on BioPortfolio along with dozens of Pancreatic Cancer Action Network Clinical Trials and PubMed Articles about Pancreatic Cancer Action Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pancreatic Cancer Action Network Companies in our database. You can also find out about relevant Pancreatic Cancer Action Network Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record